Your browser doesn't support javascript.
loading
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.
Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto.
Affiliation
  • Bandini C; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Mereu E; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Paradzik T; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Labrador M; Department of Physical Chemistry, Rudjer Boskovic Insitute, Zagreb, Croatia.
  • Maccagno M; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Cumerlato M; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Oreglia F; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Prever L; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Manicardi V; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Taiana E; Laboratory of Translational Research, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Ronchetti D; Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy.
  • D'Agostino M; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Gay F; Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy.
  • Larocca A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Besse L; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Merlo GR; Città Della Salute e della Scienza Hospital, Turin, Italy.
  • Hirsch E; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Ciarrocchi A; Città Della Salute e della Scienza Hospital, Turin, Italy.
  • Inghirami G; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Neri A; Città Della Salute e della Scienza Hospital, Turin, Italy.
  • Piva R; Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.
Exp Hematol Oncol ; 12(1): 71, 2023 Aug 10.
Article in En | MEDLINE | ID: mdl-37563685
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Exp Hematol Oncol Year: 2023 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Exp Hematol Oncol Year: 2023 Type: Article Affiliation country: Italy